Navigation Links
Three-Year Clinical Outcomes from Use of Genous™ Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy
Date:11/8/2011

aspirin administration was indefinite.

"For patients treated with Genous, our typical prescription of dual antiplatelet therapy (DAPT) is 30 days," said Robbert de Winter, M.D., Ph.D., of the Academic Medical Center, Amsterdam. "In this large, unselected patient population, there was also a segment of patients who were contraindicated to long-term DAPT and thus received less than 30 days of DAPT. For this reason, it was particularly striking there were only two cases of early stent thrombosis and that no thrombosis was observed after one month through the three year follow up, attesting to the excellent safety profile of Genous in a real world setting."

Please visit the following link to hear Prof. de Winter discuss these data: http://youtu.be/qFLGkc2PaXg.

About Genous  

Genous is OrbusNeich's patented endothelial progenitor cell (EPC) capture technology that promotes the accelerated natural healing of the vessel wall after the implantation of blood-contact devices such as stents. The technology consists of an antibody surface coating that attracts EPCs circulating in the blood to the device to form an endothelial layer that provides protection against thrombosis and modulates restenosis.

The Genous Stent, which has been commercially available in more than 60 countries since 2005, has been proven as a safe, effective alternative to drug eluting stents and is supported by data from more than 7,000 patients in company-sponsored clinical studies. There is a growing body of evidence from multiple clinical studies that the Genous Stent is effective for patients who are non-responsive to or cannot tolerate long-term dual antiplatelet therapy.

About OrbusNeich

OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world's first pro-healing stent, th
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
2. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
3. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
4. MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices
5. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
6. Comfort Medical Supply, LLC Ranks No. 461 on the 2010 Inc. 500 with Three-Year Sales Growth of 649%
7. Universal SmartComp Ranks No. 503 Overall and No. 35 in the Health Sector on the 2010 Inc. 5000 with Three-Year Sales Growth of 600%
8. Three-Year Follow-Up Data Confirm Safety and Survival Benefit in Chinese Liver Failure Patients Treated With ELAD® Bioartificial Liver
9. Auxilium Pharmaceuticals Announces Additional Data from Three-Year XIAFLEX® Recurrence Study in Dupuytrens Contracture in E-poster at ASSH Meeting
10. MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)...  The management team at Columbia Laboratories, Inc. ... conference call on July 31, 2014, to discuss ... 30, 2014.  The call details are as follows:Date: ... EDTDial-in numbers: , Toll free: (877) 870-4263 (U.S.), ... archive): , www.columbialabs.com , under ,Investor, or ...
(Date:7/23/2014)... July 23, 2014 Global healthcare ... is facing currency headwinds, increased price competition and supply ... Andrew Witty points out that the company is ... as reason to be confident about long-term prospects as ... growth. CFO Simon Dingemans adds ...
(Date:7/23/2014)... DUBLIN , July 23, 2014 ... addition of the "Prepackaged Medical Kits and ... to their offering. ... worldwide markets for Prepackaged Medical Kits and Trays ... ENT Custom Trays, Ophthalmic Custom Trays, Custom Basin ...
Breaking Medicine Technology:Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2
... 20 Today, Family Research,Council President Tony Perkins ... Shinya Yamanaka. Thomson, the first to grow human ... in the journals Science,and Cell, respectively, showing that ... human skin cells, without first creating or,destroying human ...
... International,Corporation (Nasdaq: PRXL ), a ... Dr. Victor Kiri, formerly with GlaxoSmithKline,as ... Clinical Research,Services business. Dr. Kiri,s responsibilities ... conduct of comparative observational studies, offering,epidemiological ...
Cached Medicine Technology:PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 2PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 3PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 4
(Date:7/23/2014)... DC (PRWEB) July 23, 2014 ... for ATA 2015, ATA’s twentieth annual meeting and ... The meeting, expected to attract over 5,000 attendees ... will take place May 3-5, 2015, in Los ... most renowned healthcare technology professionals from researchers, clinicians, ...
(Date:7/23/2014)... ( FXS ) is a genetic disorder that causes ... autistic spectrum, as well as cognitive deficits. It is ... the most common cause of autism. , Now biomedical ... a study that sheds light on the ... (July 23) in the Journal of Neuroscience , ...
(Date:7/23/2014)... Olympic gold medal-winning speed skater Chad Hedrick ... July 18. Hedrick visited Roanoke as the special guest ... Olympic-style event celebrating its 25th Anniversary in 2014. Foot ... sponsor of the Commonwealth Games, which like Foot Levelers ... all activity levels. , Hedrick, a native of Houston, ...
(Date:7/23/2014)... Amy Norton HealthDay ... The timing of a girl,s first menstrual period may be ... new study suggests. Researchers have identified over 100 ... menarche -- a woman,s first menstrual period. The researchers hope ... number of diseases ranging from type 2 diabetes to breast ...
(Date:7/23/2014)... 2014 Texas Physical Therapy Specialists (TexPTS) ... their Westlake, Westgate, Liberty Hill, Parmer, Balcones, and Georgetown ... of Orthopaedic Certified Specialist (OCS) or ... PT, DPT, OCS, Tony Lauretta, PT, DPT, OCS, Jason ... Joseph Leech, PT, DPT, OCS, and Mary Grimberg, PT, ...
Breaking Medicine News(10 mins):Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3Health News:US Olympian Chad Hedrick Visits Foot Levelers 2Health News:Gene Study Gives New Insight Into Puberty in Girls 2Health News:Gene Study Gives New Insight Into Puberty in Girls 3Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3
... the millions of Americans whose vision is slowly ebbing due ... cell may be riding to the rescue. ,In ... fetal stem cells have been shown to protect the vision ... of diseases that afflict humans. The new study appears today ...
... Diabetes and high blood pressure, two conditions rooted in ... than race alone in determining// who is mostly likely ... from cardiologists at Johns Hopkins. Each year, nearly 300,000 ... ,Experts say that racial disparities have long been known ...
... be a decade or more before science is available to ... way the agency approves knockoffs of traditional drugs. ... benefit companies such as Amgen Inc. and Genentech Inc, which ... products, some of the most complex and expensive on the ...
... LEXINGTON, Ky. − When studying a new blood thinner, one ... a slight increase in minor bleeding—nose bleeds and bruising,// an ... the leading cause of heart attack and stroke. While potentially ... bleeding in some patients, requiring frequent monitoring of blood levels. ...
... ancient parasitic disease causing tennis-ball-size ulcers so painful that ... in less than two years// become the second illness ... water treatment and other preventive methods, the United Nations ... the culmination of years of effort by local and ...
... Hewitt, the health secretary said that computer based therapy ... and anxiety//. This will be available to all patients ... Fear fighter and Beating the blues have been designed ... health experts have warned that computer aided programs may ...
Cached Medicine News:Health News:Stem Cell Therapy Shows Promise for Rescuing Deteriorating Vision 2Health News:Stem Cell Therapy Shows Promise for Rescuing Deteriorating Vision 3Health News:Who Gets Heart Failure? Race Takes Back Seat to Diabetes and High Blood Pressure 2Health News:Who Gets Heart Failure? Race Takes Back Seat to Diabetes and High Blood Pressure 3Health News:FDA Cites Challenges of Generic Biotech 2Health News:New Blood Thinner May Work Without Bleeding Risk 2Health News:Ancient Worm Disease Could Be Eradicated Within Two Years, UN Agency Reports 2Health News:Computer Based Therapy For Depression 2
Monitorr ICP external CSF drainage system with self-contained ICP setting....
... Sophysa external neurological drainage system combines ... all the essential functions for CSF ... technological solutions contribute to make this ... is available as a single item ...
... for neuro and skull base surgery. ... craniofacial surgery, pediatric neurosurgery, bony defects ... skull base regions, neuro trauma. Dedicated ... implants in one compact kit. MRI ...
14 cm - 5 1/2, 6.0 mm , for drill handles and hand drills....
Medicine Products: